2016年12月6日

對回波療法,INC .,鉑金管理,馬克NORDLICHT伯納德·福克斯醫療技術創新,邁克爾•戈德堡謝潑德戈德堡和亞曆克·戈德堡新聞提供的12月6日2016年,紐約17:03等分享這篇文章,12月6日,2016年11月29日從2016年曼徹斯特管理公司及其附屬公司(“原告)投訴在紐約南區聯邦地區法院對回波療法,INC .(“回聲”)(OTC-BB貿易標誌:“ETCE”),鉑金管理、鉑、馬克·NORDLICHT伯納德·福克斯醫療技術創新亞洲有限公司(“MTIA”),邁克爾·戈德堡(首席執行官Navidea生物製藥),牧羊人GOLDBERG和亞曆克·戈德堡。集體,起訴書中稱,“白金/戈德堡/ MTIA被告”,其他項目,違反聯邦證券法包括部分10 b和規則10 b-5 1934年證券交易法和合謀竊取知識產權的回聲。這源於先前的盜竊和當前試圖竊取的關鍵IP的回聲。與此類訴訟,原告在提起這樣的日期也尋求訂單顯示原因,其他救濟,一個臨時禁令對鉑/戈德堡/ MTIA被告阻止鉑/戈德堡/ MTIA被告回聲和采取任何行動的任何資產轉移到下屬原告的權利和其他高級筆記持有人(“有望”)。2016年11月29日,最高法院授予原告有望的運動。曼徹斯特了原告的購買者高級擔保本票的回聲在大約2015年12月和2016年5月進行的私人配售。與私人配售,鉑金被任命為間接代理的所有Noteholders。然而,呼應,領導和控製各種鉑/戈德堡/ MTIA被告各種相信虛假信息披露,被認為是欺詐和/或未能披露,其他項目,:鉑和其附屬公司的秘密控製與鉑金的戈德堡是子公司,邁克爾•戈德堡前執行,控製人,投資組合經理鉑沒有披露他的實益擁有權的證券的回聲與鉑金鉑金依照書麵協議。各種鉑/戈德堡/ MTIA被告已經密謀,偷走了某些回聲關鍵資產和正密謀竊取回聲的剩餘材料知識產權資產,包括但不限於,葡萄糖監測算法的源代碼和技術相關的版本2,後來版本3回聲的連續葡萄糖監測。過去5個月,曼徹斯特提供了一係列實質性的和可信的建議金融和振興回聲包括注入資本和管理的專業知識。 Every such proposal has been rejected by one or more of the Platinum/Goldberg/MTIA Defendants. In particular, the Goldbergs, as the sole directors of the Board of Echo, have repeatedly placed their personal interests above those of Echo and the holders of its securities while repeatedly threatening to shutter operations at Echo rather than consider any proposals other than the transfer of Echo's intellectual property to MTIA. This intellectual property was developed at an estimated cost of over $100 million. These and other actions leave legal action as our only remaining avenue to protect our investment and the rights of shareholders and debt holders. We have been and remain committed to our efforts to save the company and its assets, human and otherwise. Only bad faith negotiations, continued attempted self-dealing and other actions by the current board and management driven by undisclosed conflicts of interest have prevented us from commencing this new chapter in the development of the Echo technology. We remain hopeful that the current directors and officers of Echo will step aside and allow us to create value as we have done in the past at other companies. Interested parties should contact: Ryan Whalen, Member | Gusrae Kaplan Nusbaum PLLC | 120 Wall Street | New York, NY 10005 | T:(212) 269-1400 | To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/manchester-management-llc-reports-new-york-federal-court-grants-temporary-restraining-order-against-echo-therapeutics-inc-platinum-management-mark-nordlicht-bernard-fuchs-medical-technologies-innovation-michael-goldberg-s-300374027.html SOURCE Manchester Management LLC